熊去氧胆酸治疗原发性胆汁性肝硬化患者。
Ursodeoxycholic acid treatment in a patient with primary biliary cirrhosis.
作者信息
Wouters R S, Bos L P, Engels L G
机构信息
Department of Gastroenterology, Maaslandziekenhuis, Sittard.
出版信息
Neth J Med. 1990 Aug;37(1-2):21-3.
PMID:2215828
Abstract
A women with stage I-II primary biliary cirrhosis was treated with ursodeoxycholic acid (UDCA). During UDCA treatment a notable improvement in biochemical liver profile was achieved. Liver histology did not deteriorate after one year UDCA. UDCA offers a promising non-toxic alternative in the treatment of PBC.
摘要
一名患有I-II期原发性胆汁性肝硬化的女性接受了熊去氧胆酸（UDCA）治疗。在UDCA治疗期间，肝脏生化指标有显著改善。UDCA治疗一年后肝脏组织学并未恶化。UDCA为原发性胆汁性肝硬化的治疗提供了一种有前景的无毒替代方案。
Zotero 插件